Eagle Pharmaceuticals
EGRX
#9785
Rank
NZ$19.89 M
Marketcap
$1.54
Share price
25.71%
Change (1 day)
-89.64%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$19.89 Million

As of November 2024 Eagle Pharmaceuticals has a market cap of NZ$19.89 Million. This makes Eagle Pharmaceuticals the world's 9785th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$19.89 M-81.47%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
NZ$15.82 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$638.73 B 3,210,093.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$117.30 B 589,457.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$354.34 B 1,780,786.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$33.01 B 165,839.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$265.86 B 1,336,083.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.214 T 6,104,237.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$201.49 B 1,012,565.67%๐Ÿ‡บ๐Ÿ‡ธ USA